Canada Goose
GOOS
7.55
-0.09
-1.18%
Canada Goose
US · GOOS
#3475 by market cap
Listed 2017
7.55
-0.09
-1.18%
Live - 5344 symbols - heartbeat 281s ago
· 2026-10-08 08:09
Pre-market
7.55
0.00%
After-hours
7.55
0.00%
Overnight
7.54
-0.13%
- Market cap
- 737.34M
- P/E (TTM)i
- 18.24
- P/Bi
- 2.00
- EPSi
- 0.16
- Div yieldi
- 0.00%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on GOOS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.14, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +13.33% YoY
Margins
- Gross margin
- 69.72%
- Operating margin
- 5.81%
- Net margin
- 1.47%
Key ratios & quality
- Enterprise valuei
- 832.54M
- Altman Z-Scorei
- 2.14
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 830.50M | 958.10M | 903.70M | 1.10B | 1.22B | 1.33B | 1.35B | 1.53B |
| Gross profit | 516.80M | 593.30M | 554.00M | 733.60M | 815.20M | 917.40M | 943.10M | 1.07B |
| Selling & admin expenses | 302.10M | 406.20M | 437.00M | 574.10M | 667.60M | 792.90M | 779.00M | 976.70M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 196.70M | 187.10M | 117.00M | 159.50M | 147.60M | 124.50M | 164.10M | 88.80M |
| Pretax profit | 182.50M | 158.70M | 86.10M | 117.70M | 93.50M | 75.70M | 128.10M | 53.80M |
| Tax | 38.90M | 10.70M | 15.80M | 23.10M | 24.60M | 17.60M | 24.50M | 26.00M |
| Net profit | 143.60M | 148.00M | 70.30M | 94.60M | 68.90M | 58.10M | 103.60M | 27.80M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Diluted EPS | 1.28 | 1.33 | 0.63 | 0.87 | 0.69 | 0.57 | 0.97 | 0.23 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 384.60M | 107.80M | 272.60M | 694.50M | 453.30M | 118.90M |
| Gross profit | 274.40M | 66.20M | 170.10M | 513.80M | 315.40M | 74.20M |
| Selling & admin expenses | 219.30M | 224.90M | 187.70M | 313.60M | 250.50M | 178.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 55.10M | -158.70M | -17.60M | 200.20M | 64.90M | -103.80M |
| Pretax profit | 45.10M | -164.10M | -29.10M | 188.80M | 58.20M | -124.90M |
| Tax | 17.40M | -38.60M | -11.70M | 50.80M | 25.50M | -31.90M |
| Net profit | 27.70M | -125.50M | -17.40M | 138.00M | 32.70M | -93.00M |
| Basic EPS | 0 | -1 | 0 | 1 | 0 | -1 |
| Diluted EPS | 0.28 | -1.29 | -0.16 | 1.36 | 0.28 | -0.93 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 413.20M | 531.80M | 896.90M | 762.30M | 863.20M | 740.80M | 890.40M | 968.40M |
| Cash & ST investments | 88.60M | 31.70M | 477.90M | 287.70M | 286.50M | 144.90M | 334.40M | 408.20M |
| Inventory | 267.30M | 412.30M | 342.30M | 393.30M | 472.60M | 445.20M | 384.00M | 386.30M |
| Total assets | 725.40M | 1.09B | 1.48B | 1.34B | 1.59B | 1.48B | 1.63B | 1.75B |
| Total current liabilities | 136.60M | 208.90M | 262.10M | 281.50M | 352.40M | 332.90M | 343.60M | 368.50M |
| Short-term debt | -- | 35.90M | 45.20M | 62.30M | 103.70M | 89.30M | 88.20M | 97.00M |
| Long-term debt | 145.20M | 158.10M | 367.80M | 366.20M | 391.60M | 388.50M | 407.70M | 406.40M |
| Total liabilities | 326,300,000.00 | 593,400,000.00 | 900,900,000.00 | 912,700,000.00 | 1,112,500,000.00 | 1,058,100,000.00 | 1,075,300,000.00 | 1,125,400,000.00 |
| Total equity | 399.10M | 497.30M | 577.60M | 427.90M | 477.50M | 423.50M | 556.60M | 627.80M |
| Retained earnings | 279.70M | 366.80M | 437.10M | 290.40M | 316.50M | 252.50M | 346.70M | 369.20M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 890.40M | 783.70M | 815.40M | 1.04B | 968.40M | 838.20M |
| Cash & ST investments | 334.40M | 180.50M | 94.20M | 346.90M | 408.20M | 206.90M |
| Inventory | 384.00M | 439.50M | 460.70M | 408.70M | 386.30M | 489.90M |
| Total assets | 1.63B | 1.53B | 1.61B | 1.80B | 1.75B | 1.69B |
| Total current liabilities | 343.60M | 388.60M | 431.20M | 488.00M | 368.50M | 359.70M |
| Short-term debt | 88.20M | 96.80M | 134.30M | 107.90M | 97.00M | 111.40M |
| Long-term debt | 407.70M | 388.60M | 416.00M | 399.60M | 406.40M | 419.20M |
| Total liabilities | 1,075,300,000.00 | 1,083,900,000.00 | 1,170,500,000.00 | 1,216,300,000.00 | 1,125,400,000.00 | 1,149,000,000.00 |
| Total equity | 556.60M | 446.60M | 436.30M | 580.30M | 627.80M | 543.30M |
| Retained earnings | 346.70M | 221.50M | 206.30M | 341.10M | 369.20M | 278.40M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 73.40M | 51.50M | 288.60M | 151.60M | 116.30M | 164.60M | 292.40M | 191.90M |
| Depreciation & amortization | 22.70M | 57.10M | 77.40M | 95.80M | 109.10M | 126.00M | 130.70M | 131.50M |
| Free cash flow | 24.10M | 200.00K | 261.70M | 114.40M | 68.20M | 108.10M | 274.00M | 141.40M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -38.70M | 4.00M | -246.10M | -26.70M | 100.00K | 600.00K | 500.00K |
| Ending cash balance | 88.60M | 31.70M | 477.90M | 287.70M | 286.50M | 144.90M | 334.40M | 408.20M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 137.70M | -143.60M | -115.30M | 336.20M | 113.80M | -190.70M |
| Depreciation & amortization | 33.20M | 31.20M | 31.70M | 33.20M | 35.40M | 36.10M |
| Free cash flow | 134.70M | -144.10M | -125.50M | 320.40M | 90.60M | -195.40M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | 500.00K | 0 | 1.70M |
| Ending cash balance | 334.40M | 180.50M | 94.20M | 346.90M | 408.20M | 206.90M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 44.69 | 33.00 | 12.53 | 18.40 | 16.20 | 13.18 | 19.79 | 3.91 |
| ROA %i | 22.55 | 16.51 | 5.36 | 6.64 | 4.96 | 3.80 | 6.12 | 1.34 |
| ROIC %i | 33.36 | 22.98 | 8.63 | 10.33 | 8.42 | 7.53 | 10.35 | 3.26 |
| 5-year avg ROE %i | 34.66 | 36.42 | 31.74 | 31.78 | 25.16 | 18.86 | 16.21 | 14.38 |
| EBIT margin %i | 23.67 | 19.28 | 12.53 | 13.33 | 10.32 | 8.78 | 12.54 | 6.10 |
| FCF / sales %i | 2.90 | 0.02 | 28.96 | 10.42 | 5.60 | 8.10 | 20.32 | 9.25 |
| Current ratioi | 3.02 | 2.55 | 3.42 | 2.71 | 2.45 | 2.23 | 2.59 | 2.63 |
| Quick ratioi | 0.83 | 0.36 | 2.00 | 1.18 | 0.96 | 0.73 | 1.29 | 1.46 |
| Debt / assetsi | 20.02 | 35.39 | 42.11 | 46.30 | 47.42 | 49.16 | 45.52 | 44.79 |
| LT debt / equityi | 36.38 | 70.40 | 99.97 | 130.50 | 138.51 | 153.26 | 120.95 | 113.12 |
| Interest coveragei | 13.94 | 8.80 | 4.16 | 5.10 | 3.91 | 2.83 | 4.12 | 2.37 |
| Revenue CAGR (3Y) %i | 41.87 | 33.38 | 15.19 | 9.77 | 8.30 | 13.86 | 7.07 | 7.89 |
| Net income CAGR (3Y) %i | 75.68 | 89.93 | -9.90 | -12.99 | -21.10 | -5.99 | 0.07 | -32.36 |
| FCF CAGR (3Y) %i | -- | -75.19 | 41.49 | 68.06 | 598.64 | -25.53 | 33.80 | 27.51 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 19.79 | 12.09 | 6.75 | 4.06 | 3.91 | 11.88 |
| ROA %i | 6.12 | 3.15 | 1.66 | 1.22 | 1.34 | 3.53 |
| ROIC %i | 10.35 | 6.56 | 3.99 | 3.47 | 3.26 | 6.57 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.54 | 7.62 | 5.83 | 5.35 | 6.10 | 8.90 |
| FCF / sales %i | 20.32 | 20.11 | 14.80 | 12.71 | 9.25 | 5.85 |
| Current ratioi | 2.59 | 2.02 | 1.89 | 2.12 | 2.63 | 2.33 |
| Quick ratioi | 1.29 | 0.73 | 0.66 | 1.18 | 1.46 | 0.87 |
| Debt / assetsi | 45.52 | 47.17 | 49.42 | 41.94 | 44.79 | 49.25 |
| LT debt / equityi | 120.95 | 144.80 | 155.69 | 114.18 | 113.12 | 137.29 |
| Interest coveragei | 4.12 | 2.60 | 2.10 | 2.09 | 2.37 | 3.11 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Direct-to-consumer (DTC) is the largest reported line at 71.32% of revenue, across 3 reported segments.
- The next-largest line, Wholesale, is a distant second at 25.06% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Direct-to-consumer (DTC)71.32%
Wholesale25.06%
Other3.62%
Quote time 2026-10-08 08:09:50 · For reference only, not investment advice and not tailored to your situation.